Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and raises the price target from $4 to $14.
Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and raises the price target from $4 to $14.